Crossmark

Nanoparticle theranostics for respiratory diseases: advances and challenges in asthma, lung cancer, and tuberculosis

Crossref DOI link: https://doi.org/10.1186/s43168-025-00507-x

Published Online: 2025-12-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Feyzbakhsh, Hossein https://orcid.org/0009-0004-6687-8737
License Information

Text and Data Mining valid from 2025-12-18

Version of Record valid from 2025-12-18
More Information

Article History

Received: 1 September 2025

Accepted: 11 December 2025

First Online: 18 December 2025

Declarations

:

: The authors declare no competing interests.